David KARSENTI
David KARSENTI
Explore linked clinical trials.1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EYEMAX® Versus SPYGLASS™ DS for Biliary Stricture Diagnosis | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm | Not yet recruiting | Not applicable | 2026-06-02 | NCT07620080 |